Syedah Neha Ashraf
Research Subjects
Syedah Neha Ashraf has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Alisa Zyryanova
Cambridge Institute for Medical Research, Department of Clinical Biochemistry, University of Cambridge, Cambridge CB2 0XY, United Kingdom
1 shared publication - Anders Gunnarsson
AstraZeneca (Sweden)
1 shared publication - Anthony D. Keefe
X-Chem Inc., Waltham, Massachusetts, USA
1 shared publication - Argyrides Argyrou
Discovery Sciences, R&D
1 shared publication - Christopher D. Hupp1 shared publication
- Daisy Stringfellow
Neuroscience, R&D, AstraZeneca, Cambridge, UK
1 shared publication
Latest Publications
- 2 November 2026
- Published by Elsevier
Mechanistic characterization of heterobifunctional modalities using biochemical methods
- 2 November 2026
- Published by Elsevier
Mechanistic characterization of heterobifunctional modalities using biochemical methods
- Open Access
A molecular stabiliser of an inhibitory eIF2B-eIF2(αP) complex activates the Integrated Stress Response
Eukaryotic initiation factor 2B (eIF2B), a guanine nucleotide exchange factor (GEF), promotes protein synthesis by charging translation initiation factor 2 (eIF2) with GTP. Stress-induced phosphorylation of eIF2 on its α-subunit [eIF2(αP)] inhibits this reaction triggering a protective Integrated Stress Response (ISR). A DNA-encoded chemical library (DEL) screen for modulators of eIF2B, led to the identification of a chemical series that inactivates eIF2B, stimulating the ISR. Cryo-EM of compound-bound eIF2B revealed a conformational switch to the inactive state engaged by eIF2(αP). In cells, compound activity was sensitive to eIF2’s phosphorylation state and to a competing eIF2B ligand (ISRIB) that activates the GEF allosterically. These findings mark the discovery of a first-in-class drug-like allosteric inhibitor of eIF2B, an ISR activator (ISRAC), paving the way to explore the therapeutic potential of eIF2B-directed ISR activation.
Open AccessA molecular stabiliser of an inhibitory eIF2B-eIF2(αP) complex activates the Integrated Stress Response
Eukaryotic initiation factor 2B (eIF2B), a guanine nucleotide exchange factor (GEF), promotes protein synthesis by charging translation initiation factor 2 (eIF2) with GTP. Stress-induced phosphorylation of eIF2 on its α-subunit [eIF2(αP)] inhibits this reaction triggering a protective Integrated Stress Response (ISR). A DNA-encoded chemical library (DEL) screen for modulators of eIF2B, led to the identification of a chemical series that inactivates eIF2B, stimulating the ISR. Cryo-EM of compound-bound eIF2B revealed a conformational switch to the inactive state engaged by eIF2(αP). In cells, compound activity was sensitive to eIF2’s phosphorylation state and to a competing eIF2B ligand (ISRIB) that activates the GEF allosterically. These findings mark the discovery of a first-in-class drug-like allosteric inhibitor of eIF2B, an ISR activator (ISRAC), paving the way to explore the therapeutic potential of eIF2B-directed ISR activation.